The team measured body composition, physical function, disease activity, systemic inflammation, and the circulating insulin-like growth factor (IGF) system at baseline and at 12 and 24 weeks.

• 研究组分别在第12周和第24周检测了基线上人体成分，生理功能，疾病活动性，全身炎症和循环系统胰岛素样生长因子(IGF)系统。